Clinical Trials Directory

Trials / Unknown

UnknownNCT03178747

Tzanck Smear With Methylene Blue Stain for Herpes

A Comparative Study of Tzanck Smear With Methylene Blue Versus Giemsa Stain to Diagnose Herpes Simplex, Herpes Zoster and Varicella Zoster Skin Infections

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Chulalongkorn University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To compare the sensitivity of Tzanck smear with methylene blue stain versus traditional Giemsa stain in patients with herpes infection.

Detailed description

A smear from the lesional skin of the patients suspected having Herpes simplex, Herpes zoster and Varicella zoster skin infections will be collected (in a clinical routine setting). The specimen will be stained with methylene blue in addition to the Giemsa stain. Polymerase chain reaction study for herpes antigen will be performed in some of the specimens. The sensitivity, specificity, positive predictive value and negative predictive value will be calculated from the results of the study.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMethylene blueworking solution methylene blue
DIAGNOSTIC_TESTGiemsa stainworking solution Giemsa stain (Wolbach's modification)

Timeline

Start date
2017-03-07
Primary completion
2017-12-07
Completion
2018-03-06
First posted
2017-06-07
Last updated
2017-08-04

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT03178747. Inclusion in this directory is not an endorsement.

Tzanck Smear With Methylene Blue Stain for Herpes (NCT03178747) · Clinical Trials Directory